-
Notifications
You must be signed in to change notification settings - Fork 0
/
Neuroblastoma_Metadata.txt
137 lines (137 loc) · 33.3 KB
/
Neuroblastoma_Metadata.txt
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
TARGETID SampleID SamplesIDshort Gender Race Ethnicity Age.at.Diagnosis.in.Days First.Event Event.Free.Survival.Time.in.Days Vital.Status Overall.Survival.Time.in.Days Year.of.Diagnosis Year.of.Last.Follow.Up INSS.Stage MYCN.status Ploidy Histology Grade Diagnostic.Category COG.Risk.Group TMM_Case TMM
PAIFXV TARGET.30.PAIFXV.01A TARGET.30.PAIFXV Female White Unknown 2004 Event 627 Dead 1111 1995 1998 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Unknown Unknown High Risk TMM ALT
PAIPGU TARGET.30.PAIPGU.01A TARGET.30.PAIPGU Female White Unknown 898 Death 435 Dead 435 1998 1999 Stage 4 Not Amplified Hyperdiploid (DI>1) Unknown Unknown Unknown High Risk TMM Telomerase
PAISNS TARGET.30.PAISNS.01A TARGET.30.PAISNS Male White Unknown 1070 Event 410 Dead 421 1998 1999 Stage 4 Not Amplified Diploid (DI=1) Unknown Unknown Unknown High Risk TMM ALT
PAIVHE TARGET.30.PAIVHE.01A TARGET.30.PAIVHE Male White Not Hispanic or Latino 1123 Event 669 Dead 1602 1999 2003 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAKYZS TARGET.30.PAKYZS.01A TARGET.30.PAKYZS Male White Not Hispanic or Latino 659 Progression 238 Alive 3587 2001 2011 Stage 4 Not Amplified Hyperdiploid (DI>1) Unknown Unknown Unknown High Risk TMM Telomerase
PAKZRH TARGET.30.PAKZRH.01A TARGET.30.PAKZRH Male White Hispanic or Latino 21 Censored 3341 Alive 3341 2001 2010 Stage 4s Not Amplified Diploid (DI=1) Favorable Undifferentiated or Poorly Differentiated Unknown Intermediate Risk NO_TMM NO_TMM
PALBFW TARGET.30.PALBFW.01A TARGET.30.PALBFW Male White Not Hispanic or Latino 804 Relapse 611 Dead 1073 2001 2004 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PALCBW TARGET.30.PALCBW.01A TARGET.30.PALCBW Female White Not Hispanic or Latino 679 Censored 4565 Alive 4565 2001 2014 Stage 4 Not Amplified Diploid (DI=1) Favorable Differentiating Neuroblastoma High Risk NO_TMM NO_TMM
PALETP TARGET.30.PALETP.01A TARGET.30.PALETP Female White Not Hispanic or Latino 1466 Death 251 Dead 251 2001 2002 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PALEVG TARGET.30.PALEVG.01A TARGET.30.PALEVG Male White Not Hispanic or Latino 666 Censored 4948 Alive 4948 2001 2015 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PALIIN TARGET.30.PALIIN.01A TARGET.30.PALIIN Male White Not Hispanic or Latino 1279 Relapse 684 Dead 1395 2002 2005 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PALKUC TARGET.30.PALKUC.01A TARGET.30.PALKUC Female Black or African American Not Hispanic or Latino 823 Censored 4399 Alive 4399 2002 2014 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PALUYS TARGET.30.PALUYS.01A TARGET.30.PALUYS Female White Not Hispanic or Latino 1214 Relapse 693 Dead 1284 2002 2006 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PALVKK TARGET.30.PALVKK.01A TARGET.30.PALVKK Female White Not Hispanic or Latino 1810 Event 217 Dead 1033 2002 2005 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM ALT
PALWVJ TARGET.30.PALWVJ.01A TARGET.30.PALWVJ Male Black or African American Not Hispanic or Latino 1544 Relapse 417 Dead 803 2002 2004 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PALXTB TARGET.30.PALXTB.01A TARGET.30.PALXTB Male White Not Hispanic or Latino 635 Censored 4257 Alive 4257 2002 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PALZZV TARGET.30.PALZZV.01A TARGET.30.PALZZV Female Black or African American Not Hispanic or Latino 699 Event 1494 Alive 1934 2002 2008 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAMEZH TARGET.30.PAMEZH.01A TARGET.30.PAMEZH Female Black or African American Not Hispanic or Latino 746 Death 330 Dead 330 2003 2004 Stage 4 Amplified Hyperdiploid (DI>1) Unknown Unknown Unknown High Risk TMM Telomerase
PAMMXF TARGET.30.PAMMXF.01A TARGET.30.PAMMXF Male Unknown Not Hispanic or Latino 1661 Relapse 140 Dead 197 2003 2004 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAMNLH TARGET.30.PAMNLH.01A TARGET.30.PAMNLH Female White Not Hispanic or Latino 1531 Relapse 361 Dead 837 2003 2005 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PAMYCE TARGET.30.PAMYCE.01A TARGET.30.PAMYCE Female White Not Hispanic or Latino 1059 Relapse 392 Dead 995 2004 2006 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAMZGT TARGET.30.PAMZGT.01A TARGET.30.PAMZGT Male White Not Hispanic or Latino 602 Relapse 603 Alive 3823 2004 2014 Stage 4 Amplified Diploid (DI=1) Unknown Unknown Neuroblastoma High Risk TMM Telomerase
PAMZMG TARGET.30.PAMZMG.01A TARGET.30.PAMZMG Female White Not Hispanic or Latino 614 Relapse 533 Dead 763 2004 2006 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PANBJH TARGET.30.PANBJH.01A TARGET.30.PANBJH Female Black or African American Not Hispanic or Latino 1030 Progression 168 Dead 920 2004 2006 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PANBMJ TARGET.30.PANBMJ.01A TARGET.30.PANBMJ Male White Not Hispanic or Latino 993 Relapse 577 Dead 3776 2004 2014 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PANGXK TARGET.30.PANGXK.01A TARGET.30.PANGXK Male White Not Hispanic or Latino 1266 Event 1855 Alive 3792 2004 2015 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk NO_TMM NO_TMM
PANJLH TARGET.30.PANJLH.01A TARGET.30.PANJLH Male White Not Hispanic or Latino 1010 Death 500 Dead 500 2004 2006 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PANKFE TARGET.30.PANKFE.01A TARGET.30.PANKFE Female White Not Hispanic or Latino 1280 Censored 402 Alive 402 2004 2006 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PANLET TARGET.30.PANLET.01A TARGET.30.PANLET Female Unknown Unknown 1973 Relapse 830 Dead 1212 2005 2008 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Unknown Ganglioneuroblastoma, nodular High Risk TMM ALT
PANNMS TARGET.30.PANNMS.01A TARGET.30.PANNMS Female White Not Hispanic or Latino 1080 Censored 3509 Alive 3509 2005 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Unknown Neuroblastoma High Risk TMM Telomerase
PANRRW TARGET.30.PANRRW.01A TARGET.30.PANRRW Male White Not Hispanic or Latino 1730 Relapse 408 Alive 2178 2005 2011 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Unknown Neuroblastoma High Risk NO_TMM NO_TMM
PANRVJ TARGET.30.PANRVJ.01A TARGET.30.PANRVJ Male White Not Hispanic or Latino 4781 Censored 3722 Alive 3722 2005 2015 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Differentiating Neuroblastoma High Risk TMM ALT
PANSBN TARGET.30.PANSBN.01A TARGET.30.PANSBN Male White Not Hispanic or Latino 2329 Relapse 505 Dead 836 2005 2007 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Differentiating Ganglioneuroblastoma, nodular High Risk NO_TMM NO_TMM
PANWRR TARGET.30.PANWRR.01A TARGET.30.PANWRR Male White Not Hispanic or Latino 2937 Progression 267 Dead 345 2005 2006 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Differentiating Neuroblastoma High Risk TMM Telomerase
PANXJL TARGET.30.PANXJL.01A TARGET.30.PANXJL Male Unknown Unknown 5734 Censored 431 Alive 431 2005 2006 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM ALT
PANYGR TARGET.30.PANYGR.01A TARGET.30.PANYGR Male Unknown Not Hispanic or Latino 993 Progression 281 Dead 283 2005 2006 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PANZRV TARGET.30.PANZRV.01A TARGET.30.PANZRV Male White Not Hispanic or Latino 72 Censored 3434 Alive 3434 2005 2015 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PANZVU TARGET.30.PANZVU.01A TARGET.30.PANZVU Male White Not Hispanic or Latino 1713 Death 934 Dead 934 2005 2008 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Unknown Neuroblastoma High Risk TMM ALT
PAPBGH TARGET.30.PAPBGH.01A TARGET.30.PAPBGH Female Native Hawaiian or other Pacific Islander Not Hispanic or Latino 1074 Relapse 470 Dead 723 2005 2007 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPBJE TARGET.30.PAPBJE.01A TARGET.30.PAPBJE Male White Not Hispanic or Latino 1860 Censored 3467 Alive 3467 2005 2015 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPBZI TARGET.30.PAPBZI.01A TARGET.30.PAPBZI Male White Not Hispanic or Latino 1710 Progression 172 Dead 430 2005 2007 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Unknown Neuroblastoma High Risk TMM Telomerase
PAPCTS TARGET.30.PAPCTS.01A TARGET.30.PAPCTS Male Black or African American Not Hispanic or Latino 2008 Relapse 2236 Dead 2636 2005 2013 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPEFE TARGET.30.PAPEFE.01A TARGET.30.PAPEFE Male Black or African American Not Hispanic or Latino 990 Progression 138 Dead 150 2005 2006 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPICY TARGET.30.PAPICY.01A TARGET.30.PAPICY Female White Not Hispanic or Latino 58 Censored 205 Alive 205 2006 2006 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PAPKWN TARGET.30.PAPKWN.01A TARGET.30.PAPKWN Female White Unknown 710 Relapse 260 Dead 465 2006 2007 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPKXS TARGET.30.PAPKXS.01A TARGET.30.PAPKXS Female White Not Hispanic or Latino 2547 Relapse 978 Dead 2384 2006 2012 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PAPLSD TARGET.30.PAPLSD.01A TARGET.30.PAPLSD Male White Not Hispanic or Latino 710 Relapse 583 Dead 1383 2006 2010 Stage 4 Not Amplified Diploid (DI=1) Unknown Unknown Neuroblastoma High Risk TMM Telomerase
PAPTAN TARGET.30.PAPTAN.01A TARGET.30.PAPTAN Male Black or African American Not Hispanic or Latino 1462 Censored 2054 Alive 2054 2006 2012 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Unknown Ganglioneuroblastoma, nodular High Risk TMM ALT
PAPTCR TARGET.30.PAPTCR.01A TARGET.30.PAPTCR Female White Not Hispanic or Latino 754 Event 394 Dead 456 2006 2007 Stage 4 Unknown Unknown Unknown Unknown Neuroblastoma High Risk NO_TMM NO_TMM
PAPTDH TARGET.30.PAPTDH.01A TARGET.30.PAPTDH Female White Not Hispanic or Latino 11 Second Malignant Neoplasm 193 Alive 2866 2006 2014 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PAPTFZ TARGET.30.PAPTFZ.01A TARGET.30.PAPTFZ Male Black or African American Not Hispanic or Latino 564 Relapse 516 Dead 779 2006 2008 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPTLV TARGET.30.PAPTLV.01A TARGET.30.PAPTLV Female White Not Hispanic or Latino 641 Relapse 366 Dead 575 2006 2008 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPUWY TARGET.30.PAPUWY.01A TARGET.30.PAPUWY Female White Not Hispanic or Latino 1955 Relapse 765 Dead 1102 2006 2009 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPVFD TARGET.30.PAPVFD.01A TARGET.30.PAPVFD Male White Not Hispanic or Latino 1961 Death 1765 Dead 1765 2006 2011 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Unknown Neuroblastoma High Risk TMM ALT
PAPVRN TARGET.30.PAPVRN.01A TARGET.30.PAPVRN Male White Not Hispanic or Latino 2300 Censored 2889 Alive 2889 2006 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Differentiating Ganglioneuroblastoma, nodular High Risk NO_TMM NO_TMM
PAPVXS TARGET.30.PAPVXS.01A TARGET.30.PAPVXS Male Black or African American Not Hispanic or Latino 1366 Death 224 Dead 224 2006 2007 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPZYP TARGET.30.PAPZYP.01A TARGET.30.PAPZYP Female White Hispanic or Latino 1010 Censored 2386 Alive 2386 2007 2013 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAPZYZ TARGET.30.PAPZYZ.01A TARGET.30.PAPZYZ Female Black or African American Not Hispanic or Latino 550 Censored 1209 Alive 1209 2007 2010 Stage 4 Amplified Hyperdiploid (DI>1) Unknown Unknown Neuroblastoma High Risk NO_TMM NO_TMM
PARACM TARGET.30.PARACM.01A TARGET.30.PARACM Female Black or African American Not Hispanic or Latino 1442 Censored 2994 Alive 2994 2007 2015 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PARACS TARGET.30.PARACS.01A TARGET.30.PARACS Male White Not Hispanic or Latino 1180 Censored 1328 Alive 1328 2007 2010 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PARAMT TARGET.30.PARAMT.01A TARGET.30.PARAMT Male White Not Hispanic or Latino 885 Death 493 Dead 493 2007 2008 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PARBAJ TARGET.30.PARBAJ.01A TARGET.30.PARBAJ Male White Not Hispanic or Latino 35 Relapse 302 Alive 2666 2007 2014 Stage 3 Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PARBAJ TARGET.30.PARBAJ.02A TARGET.30.PARBAJ Male White Not Hispanic or Latino 35 Relapse 302 Alive 2666 2007 2014 Stage 3 Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PARBGP TARGET.30.PARBGP.01A TARGET.30.PARBGP Female Black or African American Not Hispanic or Latino 3625 Relapse 1524 Dead 2039 2007 2012 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PARDCK TARGET.30.PARDCK.01A TARGET.30.PARDCK Female White Not Hispanic or Latino 2060 Censored 2991 Alive 2991 2007 2015 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Unknown Ganglioneuroblastoma, nodular High Risk TMM ALT
PARDIW TARGET.30.PARDIW.01A TARGET.30.PARDIW Male White Not Hispanic or Latino 2048 Censored 2829 Alive 2829 2007 2015 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PARFWB TARGET.30.PARFWB.01A TARGET.30.PARFWB Male White Not Hispanic or Latino 1555 Relapse 1105 Dead 1836 2007 2012 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PARGKK TARGET.30.PARGKK.01A TARGET.30.PARGKK Male Black or African American Not Hispanic or Latino 2241 Progression 1075 Dead 1321 2007 2011 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Differentiating Neuroblastoma High Risk TMM Telomerase
PARHAM TARGET.30.PARHAM.02A TARGET.30.PARHAM Female White Not Hispanic or Latino 341 Progression 38 Dead 2466 2007 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Favorable Unknown Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PARHAM TARGET.30.PARHAM.01A TARGET.30.PARHAM Female White Not Hispanic or Latino 341 Progression 38 Dead 2466 2007 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Favorable Unknown Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PARJVP TARGET.30.PARJVP.01A TARGET.30.PARJVP Male Unknown Not Hispanic or Latino 56 Censored 2064 Alive 2064 2007 2013 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PARKGJ TARGET.30.PARKGJ.01A TARGET.30.PARKGJ Male White Not Hispanic or Latino 1616 Relapse 841 Dead 1636 2007 2012 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PARNNC TARGET.30.PARNNC.01A TARGET.30.PARNNC Female White Not Hispanic or Latino 41 Relapse 735 Alive 2611 2007 2014 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PARSBI TARGET.30.PARSBI.01A TARGET.30.PARSBI Female White Not Hispanic or Latino 2390 Relapse 1377 Dead 1743 2007 2012 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PARYNK TARGET.30.PARYNK.01A TARGET.30.PARYNK Female White Hispanic or Latino 2279 Censored 2351 Alive 2351 2008 2014 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PARZCJ TARGET.30.PARZCJ.01A TARGET.30.PARZCJ Male White Not Hispanic or Latino 242 Censored 2435 Alive 2435 2008 2015 Stage 3 Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PARZHA TARGET.30.PARZHA.01A TARGET.30.PARZHA Male Unknown Unknown 3 Censored 2489 Alive 2489 2008 2015 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PARZIP TARGET.30.PARZIP.01A TARGET.30.PARZIP Male Unknown Unknown 2273 Relapse 632 Alive 2511 2008 2015 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PASCFC TARGET.30.PASCFC.01A TARGET.30.PASCFC Male White Not Hispanic or Latino 18 Censored 2522 Alive 2522 2008 2015 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PASCTR TARGET.30.PASCTR.01A TARGET.30.PASCTR Male White Not Hispanic or Latino 60 Censored 2325 Alive 2325 2008 2014 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PASEGA TARGET.30.PASEGA.01A TARGET.30.PASEGA Male White Not Hispanic or Latino 1091 Progression 469 Dead 809 2008 2010 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PASFGG TARGET.30.PASFGG.01A TARGET.30.PASFGG Female White Not Hispanic or Latino 1037 Death 700 Dead 700 2008 2010 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASFIC TARGET.30.PASFIC.01A TARGET.30.PASFIC Male White Not Hispanic or Latino 51 Censored 2152 Alive 2152 2008 2014 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PASGAP TARGET.30.PASGAP.02A TARGET.30.PASGAP Male Black or African American Not Hispanic or Latino 1330 Progression 1285 Dead 1543 2008 2013 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PASGAP TARGET.30.PASGAP.01A TARGET.30.PASGAP Male Black or African American Not Hispanic or Latino 1330 Progression 1285 Dead 1543 2008 2013 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PASGUT TARGET.30.PASGUT.01A TARGET.30.PASGUT Male White Hispanic or Latino 1259 Censored 401 Alive 401 2008 2009 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM ALT
PASHFA TARGET.30.PASHFA.01A TARGET.30.PASHFA Female White Not Hispanic or Latino 406 Progression 201 Dead 333 2008 2009 Stage 3 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASJZC TARGET.30.PASJZC.01A TARGET.30.PASJZC Female White Not Hispanic or Latino 74 Relapse 367 Alive 2083 2009 2014 Stage 4s Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PASMDM TARGET.30.PASMDM.01A TARGET.30.PASMDM Male White Not Hispanic or Latino 25 Censored 1324 Alive 1324 2009 2012 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PASMJG TARGET.30.PASMJG.01A TARGET.30.PASMJG Female Not Reported Not Hispanic or Latino 1765 Progression 1162 Dead 1544 2009 2013 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PASMNT TARGET.30.PASMNT.01A TARGET.30.PASMNT Female Native Hawaiian or other Pacific Islander Not Hispanic or Latino 4802 Progression 233 Dead 1696 2009 2013 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PASNEF TARGET.30.PASNEF.01A TARGET.30.PASNEF Female Not Reported Hispanic or Latino 696 Censored 2213 Alive 2213 2009 2015 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASNML TARGET.30.PASNML.01A TARGET.30.PASNML Male Not Reported Not Hispanic or Latino 8 Censored 2185 Alive 2185 2009 2015 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PASNPG TARGET.30.PASNPG.01A TARGET.30.PASNPG Female Black or African American Not Hispanic or Latino 318 Event 302 Alive 1918 2009 2014 Stage 3 Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PASNPG TARGET.30.PASNPG.02A TARGET.30.PASNPG Female Black or African American Not Hispanic or Latino 318 Event 302 Alive 1918 2009 2014 Stage 3 Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PASNZU TARGET.30.PASNZU.01A TARGET.30.PASNZU Male Black or African American Not Hispanic or Latino 1099 Relapse 954 Dead 1692 2009 2013 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASPBZ TARGET.30.PASPBZ.01A TARGET.30.PASPBZ Male Black or African American Not Hispanic or Latino 62 Censored 1983 Alive 1983 2009 2014 Stage 4s Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PASPER TARGET.30.PASPER.01A TARGET.30.PASPER Female White Hispanic or Latino 753 Progression 638 Alive 2087 2009 2014 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PASRFS TARGET.30.PASRFS.01A TARGET.30.PASRFS Female White Not Hispanic or Latino 1328 Relapse 1675 Alive 2075 2009 2014 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PASSRN TARGET.30.PASSRN.01A TARGET.30.PASSRN Male White Not Hispanic or Latino 5345 Censored 1947 Alive 1947 2009 2014 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASSRS TARGET.30.PASSRS.01A TARGET.30.PASSRS Male Unknown Not Hispanic or Latino 2492 Relapse 861 Dead 1319 2009 2012 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PASSWW TARGET.30.PASSWW.01A TARGET.30.PASSWW Male White Not Hispanic or Latino 7 Censored 1828 Alive 1828 2009 2014 Stage 4s Not Amplified Diploid (DI=1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PASTCN TARGET.30.PASTCN.01A TARGET.30.PASTCN Male White Not Hispanic or Latino 1900 Relapse 870 Dead 1033 2009 2012 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PASTKC TARGET.30.PASTKC.01A TARGET.30.PASTKC Male White Not Hispanic or Latino 3035 Censored 1952 Alive 1952 2009 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASUCB TARGET.30.PASUCB.01A TARGET.30.PASUCB Male White Not Hispanic or Latino 1008 Censored 1976 Alive 1976 2009 2014 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASUML TARGET.30.PASUML.01A TARGET.30.PASUML Male Black or African American Not Hispanic or Latino 4 Event 12 Dead 20 2009 2009 Stage 4s Not Amplified Diploid (DI=1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PASUYG TARGET.30.PASUYG.01A TARGET.30.PASUYG Male Black or African American Not Hispanic or Latino 1418 Relapse 505 Alive 1990 2009 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASVRU TARGET.30.PASVRU.01A TARGET.30.PASVRU Male White Hispanic or Latino 631 Event 254 Dead 440 2009 2010 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASWFB TARGET.30.PASWFB.01A TARGET.30.PASWFB Female Black or African American Not Hispanic or Latino 727 Death 87 Dead 87 2009 2009 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASWIJ TARGET.30.PASWIJ.01A TARGET.30.PASWIJ Male White Not Hispanic or Latino 2537 Censored 1940 Alive 1940 2009 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PASWVY TARGET.30.PASWVY.01A TARGET.30.PASWVY Female White Not Hispanic or Latino 2477 Censored 1918 Alive 1918 2009 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM ALT
PASWYR TARGET.30.PASWYR.01A TARGET.30.PASWYR Male White Not Hispanic or Latino 958 Censored 1893 Alive 1893 2009 2014 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASXGP TARGET.30.PASXGP.01A TARGET.30.PASXGP Male White Not Hispanic or Latino 834 Censored 1898 Alive 1898 2009 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PASXHE TARGET.30.PASXHE.01A TARGET.30.PASXHE Male Black or African American Not Hispanic or Latino 1438 Censored 2098 Alive 2098 2009 2015 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PASXIE TARGET.30.PASXIE.01A TARGET.30.PASXIE Male White Not Hispanic or Latino 837 Censored 1758 Alive 1758 2009 2014 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASXRG TARGET.30.PASXRG.01A TARGET.30.PASXRG Female White Unknown 1278 Censored 1749 Alive 1749 2009 2014 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PASXRJ TARGET.30.PASXRJ.01A TARGET.30.PASXRJ Female White Not Hispanic or Latino 583 Progression 266 Alive 1837 2009 2014 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PASYPX TARGET.30.PASYPX.01A TARGET.30.PASYPX Female White Hispanic or Latino 1514 Progression 296 Alive 1809 2009 2014 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PASZKE TARGET.30.PASZKE.01A TARGET.30.PASZKE Male White Not Hispanic or Latino 31 Death 8 Dead 8 2009 2009 Stage 4s Not Amplified Hyperdiploid (DI>1) Unknown Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PASZPI TARGET.30.PASZPI.01A TARGET.30.PASZPI Male White Not Hispanic or Latino 645 Progression 453 Dead 1014 2009 2012 Stage 4 Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PATAYJ TARGET.30.PATAYJ.01A TARGET.30.PATAYJ Male White Not Hispanic or Latino 52 Censored 1744 Alive 1744 2009 2014 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PATBMM TARGET.30.PATBMM.01A TARGET.30.PATBMM Male White Not Hispanic or Latino 1112 Relapse 709 Alive 768 2009 2011 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PATCFL TARGET.30.PATCFL.01A TARGET.30.PATCFL Male White Not Hispanic or Latino 1041 Censored 1754 Alive 1754 2009 2014 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PATDWN TARGET.30.PATDWN.01A TARGET.30.PATDWN Male Not Reported Hispanic or Latino 1435 Censored 278 Alive 278 2009 2010 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PATDXC TARGET.30.PATDXC.01A TARGET.30.PATDXC Male White Not Hispanic or Latino 1659 Event 444 Dead 916 2009 2012 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PATEPF TARGET.30.PATEPF.01A TARGET.30.PATEPF Male White Hispanic or Latino 1434 Death 304 Dead 304 2010 2010 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Ganglioneuroblastoma, nodular High Risk TMM Telomerase
PATESI TARGET.30.PATESI.01A TARGET.30.PATESI Male Black or African American Not Hispanic or Latino 752 Relapse 622 Dead 958 2010 2012 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PATFCY TARGET.30.PATFCY.01A TARGET.30.PATFCY Male White Not Hispanic or Latino 1040 Death 787 Dead 787 2010 2012 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PATFXV TARGET.30.PATFXV.01A TARGET.30.PATFXV Female White Hispanic or Latino 648 Progression 236 Dead 296 2010 2010 Stage 4 Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PATGJU TARGET.30.PATGJU.01A TARGET.30.PATGJU Female White Not Hispanic or Latino 59 Censored 1219 Alive 1219 2010 2013 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Low Risk NO_TMM NO_TMM
PATGLU TARGET.30.PATGLU.01A TARGET.30.PATGLU Male White Not Hispanic or Latino 1037 Relapse 715 Dead 1330 2010 2013 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM ALT
PATHKB TARGET.30.PATHKB.01A TARGET.30.PATHKB Male White Not Hispanic or Latino 7 Censored 1573 Alive 1573 2010 2014 Stage 4s Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PATHVK TARGET.30.PATHVK.01A TARGET.30.PATHVK Female White Not Hispanic or Latino 2109 Progression 171 Alive 1807 2010 2015 Stage 4 Not Amplified Hyperdiploid (DI>1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk NO_TMM NO_TMM
PATINJ TARGET.30.PATINJ.01A TARGET.30.PATINJ Male White Not Hispanic or Latino 1037 Relapse 736 Dead 822 2010 2012 Stage 4 Not Amplified Diploid (DI=1) Unfavorable Undifferentiated or Poorly Differentiated Neuroblastoma High Risk TMM Telomerase
PAUDDK TARGET.30.PAUDDK.02A TARGET.30.PAUDDK Male Black or African American Not Hispanic or Latino 361 Event 344 Alive 1528 2011 2015 Stage 3 Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM
PAUDDK TARGET.30.PAUDDK.01A TARGET.30.PAUDDK Male Black or African American Not Hispanic or Latino 361 Event 344 Alive 1528 2011 2015 Stage 3 Not Amplified Hyperdiploid (DI>1) Favorable Undifferentiated or Poorly Differentiated Neuroblastoma Intermediate Risk NO_TMM NO_TMM